Cargando…
Determinants of Tumor Necrosis Factor Inhibitor Use in Juvenile Spondyloarthropathy and Impact on Clinical Disease Outcomes
OBJECTIVE: The objectives of this study were to characterize the reasons for tumor necrosis factor inhibitor (TNFi) initiation in patients with juvenile spondyloarthropathy (JSpA) and identify clinical correlates and to assess the effect of TNFi therapy on JSpA disease activity. METHODS: We conducte...
Autores principales: | Oliver, Melissa, Simard, Julia F., Lee, Tzielan, Gerstbacher, Dana, Sandborg, Christy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754014/ https://www.ncbi.nlm.nih.gov/pubmed/34647693 http://dx.doi.org/10.1002/acr2.11353 |
Ejemplares similares
-
Biologic agents in juvenile spondyloarthropathies
por: Katsicas, María Martha, et al.
Publicado: (2016) -
Building a Viable Telemedicine Presence in Pediatric Rheumatology
por: Pooni, Rajdeep, et al.
Publicado: (2020) -
The new proposal classification criteria for juvenile spondyloarthropathies
por: Sezen, Metin, et al.
Publicado: (2014) -
Similarities and Differences Between Juvenile and Adult Spondyloarthropathies
por: Fisher, Corinne, et al.
Publicado: (2021) -
Pediatric subspecialty telemedicine use from the patient and provider perspective
por: Pooni, Rajdeep, et al.
Publicado: (2021)